These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33937363)

  • 21. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
    Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and comparative evaluation of a structurally unique PAI-1 inhibitor exhibiting oral in-vivo efficacy.
    Crandall DL; Elokdah H; Di L; Hennan JK; Gorlatova NV; Lawrence DA
    J Thromb Haemost; 2004 Aug; 2(8):1422-8. PubMed ID: 15304050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen activator inhibitor-1 potentiates LPS-induced neutrophil activation through a JNK-mediated pathway.
    Kwak SH; Wang XQ; He Q; Fang WF; Mitra S; Bdeir K; Ploplis VA; Xu Z; Idell S; Cines D; Abraham E
    Thromb Haemost; 2006 May; 95(5):829-35. PubMed ID: 16676075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1.
    Vousden KA; Lundqvist T; Popovic B; Naiman B; Carruthers AM; Newton P; Johnson DJD; Pomowski A; Wilkinson T; Dufner P; de Mendez I; Mallinder PR; Murray C; Strain M; Connor J; Murray LA; Sleeman MA; Lowe DC; Huntington JA; Vaughan TJ
    Sci Rep; 2019 Feb; 9(1):1605. PubMed ID: 30733557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin.
    Arroyo De Prada N; Schroeck F; Sinner EK; Muehlenweg B; Twellmeyer J; Sperl S; Wilhelm OG; Schmitt M; Magdolen V
    Eur J Biochem; 2002 Jan; 269(1):184-92. PubMed ID: 11784312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
    Whitley BR; Beaulieu LM; Carter JC; Church FC
    Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent.
    Cale JM; Lawrence DA
    Curr Drug Targets; 2007 Sep; 8(9):971-81. PubMed ID: 17896949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activator inhibitor-1 inhibitors: a patent review (2006-present).
    Fortenberry YM
    Expert Opin Ther Pat; 2013 Jul; 23(7):801-15. PubMed ID: 23521527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: The roles of PAI-1 and obesity on stroke.
    Chen R; Yan J; Liu P; Wang Z; Wang C
    Metab Brain Dis; 2017 Jun; 32(3):667-673. PubMed ID: 28378106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re: "Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus" by Bayomi et al. (Metab Syndr Relat Disord 2017;15:269-275).
    Avogaro A
    Metab Syndr Relat Disord; 2017 Aug; 15(6):266-268. PubMed ID: 28605281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can inactivators of plasminogen activator inhibitor alleviate the burden of obesity and diabetes? (Review).
    Jankun J; Al-Senaidy A; Skrzypczak-Jankun E
    Int J Mol Med; 2012 Jan; 29(1):3-11. PubMed ID: 21993838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
    Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
    Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA
    FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation.
    Kaji H
    Compr Physiol; 2016 Sep; 6(4):1873-1896. PubMed ID: 27783862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen activator levels are influenced by location and varicosity in greater saphenous vein.
    Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC; Yao JS
    J Vasc Surg; 1996 Nov; 24(5):719-24. PubMed ID: 8918314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?
    Sillen M; Declerck PJ
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasminogen activator inhibitor results in a hypofibrinolytic state in adolescents with obesity: in vivo and ex vivo evidence.
    Dietrich K; Ball GD; Mitchell LG
    Br J Haematol; 2016 Oct; 175(2):300-307. PubMed ID: 27434823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.
    Yamamoto K; Takeshita K; Kojima T; Takamatsu J; Saito H
    Cardiovasc Res; 2005 May; 66(2):276-85. PubMed ID: 15820196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1).
    Morrow GB; Mutch NJ
    Semin Thromb Hemost; 2023 Apr; 49(3):305-313. PubMed ID: 36522166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
    Rodenburg KW; Kjoller L; Petersen HH; Andreasen PA
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.